SINOVAC BIOTECH LTD (SVA) Capital expenditures 2016–2025
SINOVAC BIOTECH LTD (SVA) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$48.9MFY2025 · since FY2016: $12.7M → $48.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $48.9M | -49.0% |
| FY2024 | $96.0M | -38.6% |
| FY2023 | $156.2M | -50.2% |
| FY2022 | $313.9M | -47.2% |
| FY2021 | $594.2M | +366.1% |
| FY2020 | $127.5M | +1099.5% |
| FY2019 | $10.6M | +89.3% |
| FY2018 | $5.6M | -52.9% |
| FY2017 | $11.9M | -5.8% |
| FY2016 | $12.7M | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice